By Daniella Parra Recordati said it will acquire the global rights to Enjaymo, used to treat a rare blood disorder, from Sanofi. Enjaymo has been approved by the FDA, European Commission, and Japan’s ...
‘We don’t want to send the message to the younger generation that we’re people who have to hide ourselves.’ By Chang W. LeeMotoko Rich and Hisako Ueno The Biden administration is dealing ...